Mark Payne
Health Reporter at Law360
Health reporter @law360. Prev. Kentucky state government and politics. Member @nyguild. [email protected] (retweets ≠ endorsement).
Articles
-
2 weeks ago |
law360.com | Mark Payne
By Mark Payne · May 27, 2025, 7:14 PM EDT Amgen Inc.'s ongoing challenge to a Colorado law regulating retail drug prices could serve as a litmus test for widespread state government efforts to keep medication costs low.... To view the full article, register now.
-
3 weeks ago |
law360.com | Mark Payne
Ind. Tells Nonprofit Hospitals To Curb Prices, Or Else By Mark Payne · May 13, 2025, 5:16 PM EDT Charitable hospitals in Indiana have a choice: Lower prices or face the loss of their nonprofit status.... To view the full article, register now.
-
3 weeks ago |
law360.com | Mark Payne
By Mark Payne · May 20, 2025, 5:49 PM EDT Even as the Trump administration has been ordered to restore a screening program for black lung disease, health and legal advocates worry the federal government is neglecting the well-being of miners... To view the full article, register now.
-
1 month ago |
law360.com | Mark Payne
By Mark Payne · May 6, 2025, 5:59 PM EDT Facing a doctor shortage, Michigan lawmakers are considering a bill that would allow nurse practitioners to treat patients without oversight from a licensed doctor. The effort is already receiving pushback from... To view the full article, register now.
-
1 month ago |
law360.com | Mark Payne
By Mark Payne · May 13, 2025, 4:52 PM EDT In the years since the U.S. Supreme Court ended the federal right to abortion access, lawmakers in more than a dozen states have imposed a host of tough new legal restrictions,... To view the full article, register now.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 3K
- DMs Open
- Yes
New: Facing a doctor shortage, Michigan lawmakers are considering a bill that would allow nurse practitioners to treat patients without oversight from a licensed doctor. The effort is already receiving pushback from the state's medical board. https://t.co/1ju6YgPlWb
New analysis: While Eli Lilly has taken on numerous compounders over its popular GLP-1 drugs, two of the company's recent suits are the first time it has raised allegations that telehealth competitors are improperly engaged in "corporate" control of medical practices.
New from me: #SCOTUS on Tuesday sided with HHS in a challenge over a formula used to calculate billions in annual payments to hospitals treating indigent patients, saying those entitled to SSI should be collecting cash payments before they're counted in the formula.
